Retro Biosciences, the Sam Altman-backed startup that wants to use AI to develop therapies for extending human lifespan by a decade, is raising a $1B Series A (Financial Times)

Financial Times:
Retro Biosciences, the Sam Altman-backed startup that wants to use AI to develop therapies for extending human lifespan by a decade, is raising a $1B Series A  —  The San Francisco-based start-up plans to get its first drug into trials this year  —  Retro Biosciences is raising a $1bn round …